The Valley Desk

NCT00256750 · Interventional trial

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)

Overall registry status Completed

Phase 3

Conditions Chronic Kidney Failure, Kidney Transplantation

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov